<bill session="109" type="h" number="5975" updated="2023-01-12T17:52:33Z">
  <state datetime="2006-07-28">REFERRED</state>
  <status>
    <introduced datetime="2006-07-28"/>
  </status>
  <introduced datetime="2006-07-28"/>
  <titles>
    <title type="display">Prescription Drug Comparative Effectiveness Act of 2006</title>
    <title type="official" as="introduced">To require the Agency for Healthcare Research and Quality, in consultation with the Director of the National Institutes of Health, to conduct research to develop valid scientific evidence regarding comparative clinical effectiveness, outcomes, and appropriateness of prescription drugs, medical devices, and procedures, and for other purposes.</title>
    <title type="short" as="introduced">Prescription Drug Comparative Effectiveness Act of 2006</title>
  </titles>
  <sponsor bioguide_id="A000357"/>
  <cosponsors>
    <cosponsor bioguide_id="B000420" joined="2006-07-28"/>
    <cosponsor bioguide_id="B000944" joined="2006-07-28"/>
    <cosponsor bioguide_id="B001149" joined="2006-07-28"/>
    <cosponsor bioguide_id="E000092" joined="2006-07-28"/>
    <cosponsor bioguide_id="E000172" joined="2006-07-28"/>
    <cosponsor bioguide_id="G000536" joined="2006-07-28"/>
    <cosponsor bioguide_id="W000215" joined="2006-07-28"/>
  </cosponsors>
  <actions>
    <action datetime="2006-07-28">
      <text>Introduced in House</text>
    </action>
    <action datetime="2006-07-28" state="REFERRED">
      <text>Referred to the House Committee on Energy and Commerce.</text>
    </action>
    <action datetime="2006-08-01">
      <text>Referred to the Subcommittee on Health.</text>
    </action>
  </actions>
  <committees>
    <committee code="HSIF" name="House Energy and Commerce" subcommittee="" activity="Referral"/>
    <committee code="HSIF14" name="House Energy and Commerce" subcommittee="Health" activity="Referral"/>
  </committees>
  <relatedbills/>
  <subjects>
    <term name="Health"/>
    <term name="Clinical trials"/>
    <term name="Communication in medicine"/>
    <term name="Congressional reporting requirements"/>
    <term name="Cost effectiveness"/>
    <term name="Drugs"/>
    <term name="Economics and Public Finance"/>
    <term name="Federal aid to research"/>
    <term name="Government Operations and Politics"/>
    <term name="Government paperwork"/>
    <term name="Government publicity"/>
    <term name="Health education"/>
    <term name="Health information systems"/>
    <term name="Medical research"/>
    <term name="Medical supplies"/>
    <term name="Pharmaceutical research"/>
    <term name="Quality of care"/>
    <term name="Science, Technology, Communications"/>
  </subjects>
  <amendments/>
  <summary date="2006-09-15T15:46:06Z" status="Introduced in House">Prescription Drug Comparative Effectiveness Act of 2006 - Requires the Director of the Agency for Healthcare Research and Quality (AHRQ) to conduct or support reviews of existing evidence and research to develop evidence regarding comparative clinical effectiveness, outcomes, and appropriateness of prescription drugs, medical devices, and procedures.

Requires the Secretary of Health and Human Services to develop a coordinated plan for research on methods for measuring and comparing adverse events associated with pharmaceuticals and other medical and surgical treatments so that clinicians and patients can evaluate the comparative safety and clinical effectiveness of the alternative treatment options.

Provides for information developed from such reviews to be made available to practitioners and patients.</summary>
</bill>
